NCT05441592View on ClinicalTrials.gov

A Randomized Control Trial Assessing the Effect of Topical Tranexamic Acid on Risk of Hematoma in Breast Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

August 15, 2022

Primary Completion Date

October 22, 2024

Study Completion Date

October 22, 2024

Conditions
Hematoma Postoperative
Interventions
DRUG

Tranexamic acid injection

The breast pockets will additionally be irrigated with 150 cc of 2.67% TXA (75 cc in each breast). The TXA solution will be allowed to be sit in the breast pocket for 15 minutes and then removed after 15 minutes.

OTHER

No additional irrigation

There will be no additional irrigation after the standard surgical procedure.

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER